AF
CATX icon

Allworth Financial’s Perspective Therapeutics CATX Stock Holding History

Allworth Financial’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.06K Buy
2,071
+2,036
+5,817% +$7.69K ﹤0.01% 3941
2026
Q1 		$146 Buy
+35
New +$148 ﹤0.01% 4963

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Allworth Financial's CATX Position: Q2 2026 in Review

Allworth Financial increased its Perspective Therapeutics (CATX) stake by 5,817% in Q2 2026, buying an estimated $7.69K and bringing the position to 2,071 shares worth $7.06K. The position accounts for ﹤0.01% of the portfolio, ranked #3941.

Allworth Financial first reported a position in CATX in Q1 2026 and has held it in 2 quarters since. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Allworth Financial held 2,071 shares of Perspective Therapeutics worth $7.06K as of Q2 2026.
  • Allworth Financial bought 2,036 Perspective Therapeutics shares in Q2 2026, an estimated $7.69K.
  • Perspective Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3941 holding.
  • Allworth Financial first reported a position in Perspective Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.